Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 219.00
+6.50 (3.06%)
May 27, 2026, 5:02 PM GMT
AIM:AMS Market Cap
AIM:AMS has a market cap or net worth of 460.33 million as of May 27, 2026. Its market cap has increased by 12.54% in one year.
Market Cap
460.33M
Enterprise Value
525.15M
Revenue
228.94M
Ranking
n/a
PE Ratio
47.01
Stock Price
219.00
Market Cap Chart
Since April 11, 2000, AIM:AMS's market cap has increased from 11.11M to 460.33M, an increase of 4,044.45%. That is a compound annual growth rate of 15.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 460.33M | -2.10% |
| Dec 31, 2025 | 470.21M | 11.01% |
| Dec 31, 2024 | 423.58M | -6.07% |
| Dec 29, 2023 | 450.96M | -19.69% |
| Dec 30, 2022 | 561.49M | -23.12% |
| Dec 31, 2021 | 730.32M | 39.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.84B |
| GSK plc | 76.45B |
| Haleon | 30.46B |
| Smith & Nephew | 9.72B |
| Spire Healthcare Group | 891.33M |
| CVS Group | 841.18M |
| Oxford Biomedica | 747.29M |
| Allergy Therapeutics | 569.93M |